CVKD

Cadrenal Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

2.6%

Short % Float

1.2d to cover · Low squeeze

9.8%

Inst % Float

10 holders · 2026-06-30

Vanguard Capital M

Top Holder

1.4% of float

2.4M sh

Public Float

74/100

Dilution Score

High

2 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

74/100

HIGH

Inst: 9.79% · Top: Vanguard Capital Management LLC

Biotech Analytics

Nephrology

12.76

Dilution Risk: HIGHBiotech Grade: F

Insider Buying0

Publications70

Dilution Risk74

Clinical Trials0

Short Interest10